154 related articles for article (PubMed ID: 1543542)
1. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation.
Ben-Ari ET; Bernstein LR; Colburn NH
Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542
[TBL] [Abstract][Full Text] [Related]
2. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
3. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
[TBL] [Abstract][Full Text] [Related]
5. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
[TBL] [Abstract][Full Text] [Related]
6. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
7. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
[TBL] [Abstract][Full Text] [Related]
8. 12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells.
Bernstein LR; Bravo R; Colburn NH
Mol Carcinog; 1992; 6(3):221-9. PubMed ID: 1445622
[TBL] [Abstract][Full Text] [Related]
9. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
10. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis.
Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH
Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078
[TBL] [Abstract][Full Text] [Related]
11. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
Huang C; Ma WY; Young MR; Colburn N; Dong Z
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
Wu WS; Lin JK; Wu FY
Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
14. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles.
Heinrich R; Kraiem Z
J Clin Endocrinol Metab; 1997 Jun; 82(6):1839-44. PubMed ID: 9177393
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
[TBL] [Abstract][Full Text] [Related]
16. EGF-induced jun B-expression in transfected P19 embryonal carcinoma cells expressing EGF-receptors is dependent on Jun D.
den Hertog J; de Groot RP; de Laat SW; Kruijer W
Nucleic Acids Res; 1992 Jan; 20(1):125-30. PubMed ID: 1738590
[TBL] [Abstract][Full Text] [Related]
17. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
18. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.
Bernstein LR; Colburn NH
Science; 1989 May; 244(4904):566-9. PubMed ID: 2541502
[TBL] [Abstract][Full Text] [Related]
19. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]